[Federal Register Volume 69, Number 90 (Monday, May 10, 2004)]
[Notices]
[Pages 25910-25911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-10589]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Food Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committees: Food Advisory Committee, Dietary Supplements 
Subcommittee of the Food Advisory Committee and Contaminants and 
Natural Toxicants Subcommittee of the Food Advisory Committee. The Food 
Advisory Committee and its Dietary Supplements subcommittee will meet 
for the first portion of the meeting; the Food Advisory Committee and 
its Contaminants and Natural Toxicants subcommittee will meet for the 
second portion of the meeting.
    General Function of the Committees: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: This meeting will have two parts. The first portion 
of the meeting will be the Food Advisory Committee and its Dietary 
Supplements Subcommittee and will be held on June 7, 2004, from 8 a.m. 
until 5 p.m.; and on June 8, 2004, from 8 a.m. until 1:45 p.m.
    The second portion of the meeting will be the Food Advisory 
Committee and its Contaminants and Natural Toxicants Subcommittee and 
will be held on June 8, 2004, from 2 p.m. until 6 p.m.
    Location: Bethesda Marriott, Grand Ballroom, 5150 Pooks Hill Rd., 
Bethesda, MD.
    Contact Person: Linda L. Reed, Center for Food Safety and Applied 
Nutrition (HFS-006), Food and Drug Administration, 5100 Paint Branch 
Pkwy., College Park, MD, 301-436-2397, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 3014510564. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: FDA has received health claim petitions concerning the 
following topics: (1) Glucosamine and chondroitin sulfate and 
osteoarthritis, and (2) crystalline glucosamine sulfate and 
osteoarthritis. The purpose of the portion of the meeting of the Food 
Advisory Committee and its Dietary Supplements Subcommittee is to 
gather information and to receive advice and recommendations relating 
to the etiology of osteoarthritis, its modifiable risk factors, and the 
relevance of scientific studies cited in the petitions to 
substantiating the substance-disease relationship.
    The purpose of the portion of the meeting of the Food Advisory 
Committee and its Contaminants and Natural Toxicants Subcommittee is to 
discuss data needs pertaining to the evaluation of furan, a chemical 
formed during thermal treatments of food. Elsewhere in this issue of 
the Federal Register, FDA is publishing a notice that requests the 
submission of data and information pertaining to the occurrence of 
furan in food, its mechanism of formation as well as its mechanism of 
toxicity.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by May 24, 2004.

[[Page 25911]]

    For the portion of the meeting of the Food Advisory Committee and 
its Dietary Supplements Subcommittee, oral presentations from the 
public will be scheduled between approximately 3:30 p.m. and 5 p.m. on 
June 7, 2004.
    For the portion of the meeting of the Food Advisory Committee and 
its Contaminants and Natural Toxicants subcommittee, oral presentations 
from the public will be scheduled between approximately 4 p.m. and 5 
p.m. on June 8, 2004.
    Time allotted for each presentation may be limited. Those desiring 
to make formal oral presentations should notify the contact person 
before May 24, 2004, and submit a brief statement of the general nature 
of the evidence or arguments they wish to present, the names and 
addresses of proposed participants, the specific portion of the meeting 
at which they wish to present, and an indication of the approximate 
time requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Linda Reed at least 
7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 29, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-10589 Filed 5-7-04; 8:45 am]
BILLING CODE 4160-01-S